文献速递垂体与肾上腺疾病甲状腺疾病性腺与生殖内分泌

儿童脑肿瘤治疗后内分泌疾病:长期结局与危险因素

Endocrine disorders after treatment for pediatric brain tumors: long-Term outcomes and risk factors.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该回顾性队列纳入388例18岁前诊断的原发性脑肿瘤幸存者,随访于2000至2025年。内分泌疾病发生率为75.8%,颅咽管瘤和生殖细胞瘤最高;中央性甲状腺功能减退最常见(27.8%)。早发缺陷多与手术下丘脑-垂体损伤相关,晚发多与放化疗相关;诊断年龄小和鞍区/鞍上定位为独立预测因素。

要点

  • 儿童脑肿瘤幸存者内分泌疾病总体发生率为75.8%,颅咽管瘤和生殖细胞瘤最高。
  • 中央性甲状腺功能减退(27.8%)为最常见缺陷,其次为中央性性早熟(27.1%)。
  • 诊断年龄小和鞍区/鞍上定位独立预测内分泌疾病发生。

核心结论

  • 儿童脑肿瘤幸存者内分泌疾病发生率高,需个体化终身内分泌监测。

研究设计与样本

  • 回顾性队列研究,纳入388例18岁前诊断的原发性脑肿瘤患者,2000至2025年于三级中心随访。

主要发现

  • 内分泌疾病发生于75.8%的患者,颅咽管瘤和生殖细胞瘤患病率最高。
  • 中央性甲状腺功能减退占27.8%,中央性性早熟占27.1%,生长激素缺乏占25.8%,促肾上腺皮质激素缺乏占22.7%,中央性尿崩症占16.8%。
  • 早发缺陷通常与手术下丘脑-垂体损伤相关,晚发疾病主要与放疗或化疗相关。
  • 诊断时年龄较小和鞍区/鞍上定位独立预测内分泌疾病发生。

关键数值与推荐

  • 内分泌疾病按国际标准分类,并在诊断时及随访中行标准化内分泌评估,必要时行动态试验。

临床怎么用

  • 对儿童脑肿瘤幸存者应依据肿瘤类型、治疗方式和起病时间线进行个体化终身内分泌监测。

局限性

  • 单中心回顾性设计可能限制结果的普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Survivors of childhood brain tumors are at high risk of hypothalamic-pituitary dysfunction, but comparative data across cancer histotypes and treatment modalities are limited. This study evaluated the prevalence, risk factors, and timing of onset of hypothalamic-pituitary disorders in a large cohort of childhood brain cancer survivors, with attention to tumor type and therapeutic exposure. METHODS: A retrospective cohort of 388 patients diagnosed with primary brain tumors before 18 years of age and followed at a tertiary center between 2000 and 2025 was analyzed. Demographic, clinical, and treatment data were extracted from medical records. Standardized endocrine assessments, including dynamic testing when indicated, were performed at diagnosis and throughout follow-up. Endocrine disorders were classified by international criteria, and onset timing was recorded. RESULTS: Glioma was the most frequent histotype (66.2%), followed by medulloblastoma (19.1%), ependymoma (6.2%), craniopharyngioma (5.2%), and germ-cell tumors (3.3%). Endocrine disorders occurred in 75.8% of patients, with the highest prevalence in craniopharyngioma and germ-cell tumors. Central hypothyroidism (27.8%) was the most common deficiency, followed by central precocious puberty (27.1%), growth hormone deficiency (25.8%), adrenocorticotropic hormone deficiency (22.7%), and central diabetes insipidus (16.8%). Early-onset deficiencies were typically related to surgical hypothalamic-pituitary injury, whereas late-onset disorders were mainly associated with radiotherapy or chemotherapy. Younger age at diagnosis and sellar/suprasellar localization independently predicted endocrine morbidity. CONCLUSION: This study provides a comprehensive analysis of endocrine outcomes by tumor histotype, treatment modality, and onset timeline, underscoring the need for individualized and lifelong endocrine surveillance in survivors of childhood brain tumors.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Tuli G, Munarin J, Ragazzi P, et al. Endocrine disorders after treatment for pediatric brain tumors: long-Term outcomes and risk factors. J Clin Endocrinol Metab. 2026. PMID: 41693151. doi:10.1210/clinem/dgag064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。